We further demonstrated that the expression of KIF2C was positively associated with immune cell infiltration of the tumor microenvironment, suggesting that KIF2C may act as a potential prognostic biomarker for breast cancer immunotherapy. The gene discussed is KIF2C; the disease is breast carcinoma.